beta

CELG

Celgene Corp.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include REVLIMID, POMALYST, IMNOVID, OTEZLA, ABRAXANE, and VIDAZA. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

Market Cap: 77 Billion

Primary Exchange: NASDAQ

Website: http://www.celgene.com

Shares Outstanding: 712 Million

Float: 711 Million

Dividend: (%)

Beta: 0.579147679407984

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 723 trading days

From: 2017-10-04 To: 2019-11-19

Lowest Point:

Celgene's Long Journey Through Regulatory Filings For Ozanimod Might Finally Pay Off

via: SeekingAlpha at 2019-06-12 07:58:28:000

Celgene ( CELG ) is in good shape in terms of its multiple sclerosis ((MS)) drug ozanimod. That's because it announced that regulatory applications for the drug was accepted by both the FDA and EMA. This gives the company the potential to obtain approval for both territories. Getting thi… read more...

Celgene's Long Journey Through Regulatory Filings For Ozanimod Might Finally Pay Off

via: SeekingAlpha at 2019-06-12 07:58:28:000

Celgene ( CELG ) is in good shape in terms of its multiple sclerosis ((MS)) drug ozanimod. That's because it announced that regulatory applications for the drug was accepted by both the FDA and EMA. This gives the company the potential to obtain approval for both territories. Getting thi… read more...

How To Find Undervalued Stocks In The Healthcare Sector

via: SeekingAlpha at 2019-06-10 12:10:41:000

The healthcare sector is underperforming the market by a wide margin on a year to date basis. The Healthcare Select Sector ETF ( XLV ) has gained 5.2%, while the SPDR S&P 500 ( SPY ) is up by almost three times that, with a cumulative gain of 15.1% in the same period. Data by YCharts … read more...

How To Find Undervalued Stocks In The Healthcare Sector

via: SeekingAlpha at 2019-06-10 12:10:41:000

The healthcare sector is underperforming the market by a wide margin on a year to date basis. The Healthcare Select Sector ETF ( XLV ) has gained 5.2%, while the SPDR S&P 500 ( SPY ) is up by almost three times that, with a cumulative gain of 15.1% in the same period. Data by YCharts … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2014-06-26 2014-02-12 2014-06-18 2014-06-25 00:00:00 -0400 0.5 2.0 1.0
Data provided by IEX Cloud